IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LEALI, Daria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.755
EU - Europa 1.279
AS - Asia 430
AF - Africa 5
OC - Oceania 3
SA - Sud America 3
Totale 3.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.752
PL - Polonia 491
CN - Cina 277
DE - Germania 251
UA - Ucraina 205
GB - Regno Unito 76
FI - Finlandia 63
HK - Hong Kong 58
IT - Italia 47
SG - Singapore 37
RU - Federazione Russa 36
IE - Irlanda 35
ES - Italia 30
VN - Vietnam 22
FR - Francia 16
CZ - Repubblica Ceca 15
IN - India 12
IR - Iran 6
SE - Svezia 6
KR - Corea 5
TR - Turchia 5
AU - Australia 3
BE - Belgio 3
CA - Canada 3
MA - Marocco 3
PH - Filippine 3
GE - Georgia 2
SK - Slovacchia (Repubblica Slovacca) 2
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
EG - Egitto 1
IL - Israele 1
JP - Giappone 1
LT - Lituania 1
MU - Mauritius 1
NL - Olanda 1
PE - Perù 1
PK - Pakistan 1
Totale 3.475
Salva come PNG Salva come JPEG
Città #
Warsaw 491
Fairfield 259
Woodbridge 192
Jacksonville 157
Houston 150
Ashburn 137
Ann Arbor 133
Wilmington 106
Seattle 98
Chandler 92
Cambridge 84
Princeton 64
Beijing 62
Hong Kong 56
Nanjing 46
Dearborn 38
Dublin 35
Helsinki 32
Madrid 30
Jinan 26
Singapore 24
Brescia 21
Dong Ket 21
Nanchang 18
Des Moines 17
Shenyang 16
Changsha 14
Hebei 14
Jiaxing 14
New York 14
Shanghai 14
Brno 13
Lancaster 12
San Mateo 11
Hangzhou 8
Kunming 8
Nürnberg 7
San Diego 7
Kilburn 6
Los Angeles 6
Milan 6
Verona 6
Haikou 5
London 5
Ningbo 5
Tianjin 5
Zhengzhou 5
Ardabil 4
Augusta 4
Boardman 4
Kocaeli 4
Monmouth Junction 4
Baliuag 3
Brussels 3
Leawood 3
Munich 3
Phoenix 3
Rabat 3
Toronto 3
Wandsworth 3
Washington 3
Berlin 2
Bratislava 2
Canberra 2
Fort Lauderdale 2
Gunzenhausen 2
Hefei 2
Lanzhou 2
San Francisco 2
Santa Clara 2
Sejong 2
Yuseong-gu 2
Amsterdam 1
Barlassina 1
Cachan 1
Cairo 1
Changchun 1
Chennai 1
Chicago 1
Chiswick 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Haifa 1
L'aquila 1
Lima 1
Melbourne 1
Mesagne 1
Multan 1
New Delhi 1
Norwalk 1
Olomouc 1
Orange 1
Prague 1
Pune 1
Sabz 1
Salisbury 1
Segrate 1
Seoul 1
Sofia 1
Totale 2.687
Salva come PNG Salva come JPEG
Nome #
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 224
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 214
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 199
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 196
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 189
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 151
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 146
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 145
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 137
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 137
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 128
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 125
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 113
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 110
Heparin derivatives as angiogenesis inhibitors 102
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 93
Fibroblast growth factor-2 in angiogenesis 91
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 91
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 88
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 86
Role of inflammation in FGF2-driven angiogenesis 83
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 82
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 81
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 73
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 68
FGF2-Antagonist activity of long pentraxin-3 related peptides 62
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 59
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 58
FGF2- Antagonist activity of long pentraxin-3 58
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 57
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 52
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 42
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 21
Totale 3.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.096 124 50 53 132 71 126 120 106 80 129 50 55
2020/2021583 18 69 21 83 20 56 19 65 78 45 67 42
2021/2022278 6 65 2 1 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 3.561